NASDAQ: IRTC

iRhythm Technologies, Inc.

iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining their wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Their goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias.

The company has created a unique platform, ZIO by iRhythm, which they believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.